• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Taiwan·Healthcare·8409.TWO
Share

EBM Technologies Incorporated Stocks

NT$ 18.05Last Updated 20.10.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

NT$ 18.16M

NT$ 18.05
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Established in 1988 and headquartered in Taipei, Taiwan, EBM Technologies Incorporated is dedicated to developing and commercializing sophisticated software and integrated solutions for the global healthcare sector. The company's core offerings include a comprehensive suite of Enterprise Picture Archiving and Communication Systems (PACS). This encompasses SoliPACS, designed to unify various radiology, mammography, and dental imaging products; SoliPACS Gateway for seamless DICOM communication; SoliPACS Server, acting as a crucial interface between hospital information systems (HIS), radiology information systems (RIS), and PACS; SoliPACS Web Viewer, enabling medical professionals to remotely access, compare, and utilize DICOM-compliant images; SoliPACS Report for generating customizable diagnostic reports; and the Advanced Server Archive for robust PACS data storage. EBM also leads in mobile diagnostic technology, featuring the UDE (Ubiquitous Diagnostic Environment) App, which transforms an iPad Pro into an all-in-one standalone DICOM server, viewer, display, and AI processing unit. Their extensive MobiPACS portfolio provides a complete mobile imaging ecosystem, including MobiPACS Server for storing and processing images on mobile devices, the MobiPACS App for on-the-go viewing, MobiPACS Web Viewer for accessing images from any internet-enabled device, MobiPACS Share for cloud-based collaboration, and MobiPACS Multi, which supports connecting multiple iPads/iPad Pros for integrated image display. Beyond imaging, EBM provides a range of specialized medical technologies. These include Vital-Sign On-the-Go for real-time patient monitoring; Rad@ for viewing medical-grade images and facilitating diagnoses; a Digital Pathology Scanner that converts physical slides into digital whole-slide images; the AgileRIS App for offline reporting; EPS Pi, a viewer-ready DICOM device; and the UniGate_i (UGI) App. Furthermore, the company delivers essential information management and eHealth solutions. These comprise Telemed, linking medical facilities for enhanced collaboration; Electronic Medical Records (EMR), providing digital versions of patients' medical histories; Personal Health Records (PHR), offering individuals electronic access to their health data; and broader eHealth solutions for retrieving and reviewing patient images, vital signs, and ECG waveforms.

Company Valuation

Undervalued
6/7

Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBITDA, reasonably price

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

20.10.2026 20:11

"A Vicious Cycle": What Risks Does Rising Bond Yields Pose to the Stock Market?

20.10.2026 19:39

"The Weak Link": The risk premium on French government bonds has approached a 15-year high

20.10.2026 19:05

The success of the hair loss pill trials has boosted the developer's stock price. Should you buy them?

20.10.2026 18:41

Digital Twins: Why Kazakhstan Is Implementing Artificial Intelligence in Industry

20.10.2026 18:18

General Motors announced a $20 billion buyback. Why did its stock price fall?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026